Abstract:Tissue resident macrophages and a mesenchymal-like program control early disseminated cancer cell dormancy. Julio A. Aguirre-GhisoDepartment of Cell Biology, Department of Medicine-Oncology, Cancer Dormancy and Tumor Microenvironment Institute, Albert Einstein Cancer Center, Gruss-Lipper Biophotonics Center, Albert Einstein College of Medicine, Bronx, NY 10461, USA. Increasing evidence shows that cancer cells can disseminate from early-evolved primary lesions much earlier than the classical metastasis models predicted. The current paradigm supports that the tissue microenvironment where disseminated cancer cells (DCCs) lodge is a critical determinant of the timing of metastasis. However, how tissue-resident myeloid cells control this process is largely unclear. The lung tissue contains a resident population of alveolar macrophages (AMs), whose function in metastatic dormancy and growth is largely unexplored. Here, we used various transgenic mouse models, human sample analysis and single cell RNA-sequencing to reveal DCC heterogeneity and plasticity in the lung across disease evolution. We found a previously unrecognized role of mesenchymal- and pluripotency-like (M-like) programs driven by the transcription factor ZFP281 in coordinating early cancer cell spread and a long-lived dormancy program in early DCCs. The gene profiles revealed molecules that would allow early DCCs to crosstalk with AMs. Using a 3D Matrigel assay, we found that AMs are responsible for inducing an M-like phenotype in cancer cells (of both early and late evolved cancer cells) and exclusively suppressed growth of early lesion (EL) HER2+ cancer cells. The conditioned media (CM) from AMs was also found to induce an M-like phenotype and growth arrest of EL cells. RNA-sequencing profiling of pure EL cells and AMs that had been co-cultured revealed a reciprocal influence of the two cell types: increased ECM organization and induction of invasiveness in EL cells, as well as changes in inflammatory response and immune programs in AMs. Prediction of ligand-receptor interactions using the NATMI tool allowed for identification of signaling axis that would allow AMs to induce an M-like and growth program in EL cells. To test whether indeed AMs are inducing an M-like and growth arrest phenotype in early DCCs in lungs, we depleted AMs in mice bearing early MMTV-HER2 or late evolved E0771 breast cancer cells in lungs via intranasal instillation of clodronate liposomes or via the use of a AM=specific CD169-DTR targeting system. Following AM depletion, dormant DCCs began to proliferate and formed clusters and overt metastases. Our results support that tissue resident macrophages play a key role in limiting metastatic expansion of breast cancer cells via the induction of a DCC mesenchymal-like dormancy program. Citation Format: Julio A. Aguirre-Ghiso. Tissue resident macrophages and a mesenchymal-like program control early disseminated cancer cell dormancy [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl) nr SY31-01.

Mechanisms of disseminated cancer cell dormancy: an awakening field

The current paradigm and challenges ahead for the dormancy of disseminated tumor cells

Unveiling cancer dormancy: Intrinsic mechanisms and extrinsic forces

Dormancy and cancer stem cells: An enigma for cancer therapeutic targeting

Tumor dormancy as an alternative step in the development of chemoresistance and metastasis - clinical implications

Targeting cancer cell dormancy

TGF-beta Family Signaling Pathways in Cellular Dormancy

Unveiling the role of cellular dormancy in cancer progression and recurrence

Cellular dormancy in minimal residual disease following targeted therapy

Could senescence phenotypes strike the balance to promote tumor dormancy?

Tumor Dormancy Within the Lymphovascular Embolus Is Regulated by Multiple Metabolism-signaling Pathways

Bone marrow NG2+/Nestin+ mesenchymal stem cells drive DTC dormancy via TGF-β2

Natural Killer Cell Regulation of Breast Cancer Stem Cells Mediates Metastatic Dormancy

The role of cancer cell bioenergetics in dormancy and drug resistance

Advances in the molecular regulation mechanism of tumor dormancy and its therapeutic strategy

Abstract SY31-01: Tissue resident macrophages and a mesenchymal-like program control early disseminated cancer cell dormancy

The dormant cancer cell life cycle

Colorectal cancer cell dormancy: An insight into pathways

From ecology to oncology: To understand cancer stem cell dormancy, ask a Brine shrimp (<i>Artemia</i>)

Mesenchymal Stem Cell-Secreted Exosomes and Soluble Signals Regulate Breast Cancer Metastatic Dormancy: Current Progress and Future Outlook

Dormancy-inducing 3D-engineered matrix uncovers mechanosensitive and drug protective FHL2-p21 signaling axis